Biotransformation of ginsenoside Rf to Rh1 by recombinant β-glucosidase

Molecules

Volumn 14, Issue 6, 2009, Pages 2043-2048

  Ruan, Chang Chun ^a   Zhang, Hao ^a   Zhang, Lian Xue ^a   Liu, Zhi ^a   Sun, Guang Zhi ^a   Lei, Jun ^a   Qin, Yu Xia ^a   Zheng, Yi Nan ^a   Li, Xiang ^b   Pan, Hong Yu ^c  

^a JILIN AGRICULTURAL UNIVERSITY   (China)

^b SASKATOON RESEARCH CENTRE   (Canada)

^c JILIN UNIVERSITY   (China)

Author keywords

glucosidase; Aspergillus niger; Ginsenoside rf; Ginsenoside rh 1

Indexed keywords

BETA GLUCOSIDASE; GINSENOSIDE; GINSENOSIDE RF; GINSENOSIDE RH1; RECOMBINANT PROTEIN;

ARTICLE; ASPERGILLUS NIGER; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; SACCHAROMYCES CEREVISIAE;

ASPERGILLUS NIGER; BETA-GLUCOSIDASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GINSENOSIDES; MOLECULAR STRUCTURE; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 67649834224     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14062043     Document Type: Article

References (12)

1. Ligor, T.; Ludwiczuk, A.; Wolski, T.; Buszewski, B. Isolation and determination of ginsenosides in American ginseng leaves and root extracts by LC-MS. Anal. Bioanal. Chem. 2005, 353, 1098-1105.
2. Liu, W.; Xu, S.; Che, C. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line, Life Sci. 2000, 67, 1297-130.
3. Kim, S.; Lee, Y.; Park, J.; Lee, S. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepotoma SK-HEP-1 cells. Eur. J. Cancer 1999, 35, 507-511.
4. Lee, K.; Lee, Y.; Kim, S.; Park, J.; Lee, S. Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulation of p21 Cip/WAF1 and down-regulating cyclin E in SKHEP-1 cells. Anticancer Res. 1997, 17, 1067-1072.
5. Cho, W.; Chung, W.; Lee, S.; Leung, A.; Cheng C.; Yue K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2006, 550, 173-179.
6. Li, X.; Li, X.; Lei, J. Studies on chemical components and their pharmacological activities of Panax ginseng root. Drug Discovery and Traditional Chinese Medicine: Science, Regulation, and Globalization; Kluwer Academic Publishers: University of Maryland, Maryland, USA, 2000; pp. 95-109.
7. Akao, T.; Kida, H.; Kanaoka, M.; Hattori, M.; Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998, 50, 1155-1160.
8. Wakabayashi, C.; Hasegawa, H.; Murata, J.; Saiki I. In vivo anti-metastatic action of ginseng proto-panaxadiol saponins is based on their intestinal metabolites after oral administration. Oncol. Res. 1997, 9, 411-417.
9. Wakabayashi, C.; Hasegawa, H.; Murata, J. The expression of in vivo anti-metastatic effect of ginseng protopanaxadiol saponins is mediated by their intestinal metabolites after oral administration. J. Trad. Med. 1997, 14, 180-185.
10. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with Fatty Acid. J. Pharmacol. Sci. 2004, 95, 153-157.
11. Lei, J.; Li, X.; Gong, X.; Zheng, Y. Isolation, synthesis and structures of cytotoxic ginsenoside. Molecules 2007, 12, 2140-2150.
12. Hu, J.; Zhu, X.; Lee, K.; Zheng, Y.; Li, W.; Han, L.; Fang, Z.; Gu, L.; Sun, B.; Wang, C.; Sung, C. Optimization of ginsenosides hydrolyzing P-glucosidase production from Aspergillus niger using response surface methodology. Bio. Pharm. Bull. 2008, 31, 1870-1874.